pH-responsive microparticles of rifampicin for augmented intramacrophage uptake and enhanced antitubercular efficacy.

[1]  Nikita Devnarain,et al.  Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Adila Nazli,et al.  Strategies and Progresses for Enhancing Targeted Antibiotic Delivery. , 2022, Advanced drug delivery reviews.

[3]  A. Alexander,et al.  Tailoring the multi-functional properties of phospholipids for simple to complex self-assemblies. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[4]  H. Ding,et al.  Preparation and application of pH-responsive drug delivery systems. , 2022, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Széchenyi,et al.  Cocrystals of Tuberculosis Antibiotics: Challenges and Missed Opportunities. , 2022, International journal of pharmaceutics.

[6]  Y. Yeo,et al.  Meta-Analysis of Drug Delivery Approaches for Treating Intracellular Infections , 2022, Pharmaceutical Research.

[7]  T. A. Tabish,et al.  Stimuli-sensitive drug delivery systems for site-specific antibiotic release. , 2022, Drug discovery today.

[8]  J. Lovell,et al.  Traceless antibiotic-crosslinked micelles for rapid clearance of intracellular bacteria. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[9]  N. Sharma,et al.  Antimicrobial Activity of Synthetic Antimicrobial Peptides Loaded in Poly-Ɛ-Caprolactone Nanoparticles Against Mycobacteria and their Functional Synergy with Rifampicin. , 2021, International journal of pharmaceutics.

[10]  C. Prestidge,et al.  Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections. , 2021, Advanced drug delivery reviews.

[11]  B. Forbes,et al.  Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs. , 2021, International journal of pharmaceutics.

[12]  E. Innes,et al.  Simulated biological fluids – a systematic review of their biological relevance and use in relation to inhalation toxicology of particles and fibres , 2021, Critical reviews in toxicology.

[13]  Sanyog Jain,et al.  Tumor microenvironment responsive VEGF-antibody functionalized pH sensitive liposomes of docetaxel for augmented breast cancer therapy. , 2021, Materials science & engineering. C, Materials for biological applications.

[14]  Aldemar Gordillo-Galeano,et al.  Lipid nanoparticles with improved biopharmaceutical attributes for tuberculosis treatment. , 2021, International journal of pharmaceutics.

[15]  R. Nair,et al.  Mycobacterium tuberculosis Cells Surviving in the Continued Presence of Bactericidal Concentrations of Rifampicin in vitro Develop Negatively Charged Thickened Capsular Outer Layer That Restricts Permeability to the Antibiotic , 2020, Frontiers in Microbiology.

[16]  J. Champion,et al.  Protein Nanoparticle Charge and Hydrophobicity Govern Protein Corona and Macrophage Uptake. , 2020, ACS applied materials & interfaces.

[17]  Hayedeh Gorjian,et al.  Preparation and characterization of the encapsulated myrtle extract nanoliposome and nanoniosome without using cholesterol and toxic organic solvents: A comparative study. , 2020, Food chemistry.

[18]  A. Dar,et al.  Modulation of surface tension and rheological behavior of methyl cellulose – Amino acid based surfactant mixture by hydrophobic drug rifampicin: An insight into drug stabilization and pH-responsive release , 2020 .

[19]  P. Ravi,et al.  Self-assembled lecithin-chitosan nanoparticle improve the oral bioavailability and alter the pharmacokinetics of raloxifene. , 2020, International journal of pharmaceutics.

[20]  S. Foster,et al.  Polymersomes Eradicating Intracellular Bacteria. , 2020, ACS nano.

[21]  Pramod K. Gupta,et al.  Intramacrophage delivery of dual drug loaded nanoparticles for effective clearance of Mycobacterium tuberculosis. , 2020, Journal of pharmaceutical sciences.

[22]  L. Cuevas,et al.  Tackling two pandemics: a plea on World Tuberculosis Day , 2020, The Lancet Respiratory Medicine.

[23]  C. Prestidge,et al.  PLGA-Lipid Hybrid (PLH) Microparticles Enhance the Intracellular Uptake and Anti-Bacterial Activity of Rifampicin. , 2020, ACS applied materials & interfaces.

[24]  R. B. Walker,et al.  Co-Loading of Isoniazid-Grafted Phthalocyanine-in-Cyclodextrin and Rifampicin in Crude Soybean Lecithin Liposomes: Formulation, Spectroscopic and Biological Characterization. , 2020, Journal of Biomedical Nanotechnology.

[25]  Calvin A. Omolo,et al.  pH-responsive lipid-dendrimer hybrid nanoparticles: An approach to target and eliminate intracellular pathogens. , 2019, Molecular pharmaceutics.

[26]  C. Locht,et al.  Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis , 2019, ACS nano.

[27]  B. Rothen‐Rutishauser,et al.  Artificial Lysosomal Platform to Study Nanoparticle Long-term Stability. , 2019, Chimia.

[28]  S. Mehnath,et al.  Sericin-chitosan doped maleate gellan gum nanocomposites for effective cell damage in Mycobacterium tuberculosis. , 2019, International journal of biological macromolecules.

[29]  Chance M. Nowak,et al.  Regulating the Uptake of Viral Nanoparticles in Macrophage and Cancer Cells via a pH Switch. , 2018, Molecular pharmaceutics.

[30]  Fraser J. Scott,et al.  Evaluation of minor groove binders (MGBs) as novel anti-mycobacterial agents and the effect of using non-ionic surfactant vesicles as a delivery system to improve their efficacy , 2017, The Journal of antimicrobial chemotherapy.

[31]  V. Pillay,et al.  Development of respirable rifampicin-loaded nano-lipomer composites by microemulsion-spray drying for pulmonary delivery , 2017 .

[32]  R. O’Toole,et al.  Limitations of the Mycobacterium tuberculosis reference genome H37Rv in the detection of virulence-related loci. , 2017, Genomics.

[33]  Guimei Lin,et al.  Study of the pH-sensitive mechanism of tumor-targeting liposomes. , 2017, Colloids and surfaces. B, Biointerfaces.

[34]  K. Sadasivuni,et al.  Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers. , 2016, International journal of pharmaceutics.

[35]  E. Nardell,et al.  Inhaled drug treatment for tuberculosis: Past progress and future prospects. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Y. Yeo,et al.  Drug delivery to macrophages: Challenges and opportunities. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[37]  A. Fahr,et al.  Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation , 2016, Drug Delivery and Translational Research.

[38]  A. Wiącek,et al.  Effect of surface modification on starch/phospholipid wettability , 2015 .

[39]  Yihui Deng,et al.  A review on phospholipids and their main applications in drug delivery systems , 2015 .

[40]  E. Fattal,et al.  Pulmonary drug delivery systems for tuberculosis treatment. , 2015, International journal of pharmaceutics.

[41]  A. Okunlola.  Design of bilayer tablets using modified Dioscorea starches as novel excipients for immediate and sustained release of aceclofenac sodium , 2015, Front. Pharmacol..

[42]  R. Shunmugam,et al.  Increased bioavailability of rifampicin from stimuli-responsive smart nano carrier. , 2014, ACS applied materials & interfaces.

[43]  M. A. Croce,et al.  Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis. , 2014, International journal of pharmaceutics.

[44]  Soodabeh Davaran,et al.  Liposome: classification, preparation, and applications , 2013, Nanoscale Research Letters.

[45]  Eleonore Fröhlich,et al.  The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles , 2012, International journal of nanomedicine.

[46]  Jeffrey I. Zink,et al.  Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles , 2012, Antimicrobial Agents and Chemotherapy.

[47]  I. H. Bechtold,et al.  An Isoniazid Analogue Promotes Mycobacterium tuberculosis-Nanoparticle Interactions and Enhances Bacterial Killing by Macrophages , 2012, Antimicrobial Agents and Chemotherapy.

[48]  V. C. Malshe,et al.  Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting. , 2010, International journal of pharmaceutics.

[49]  S. Yuk,et al.  Core/shell nanoparticles for pH-sensitive delivery of doxorubicin. , 2010, Journal of Nanoscience and Nanotechnology.

[50]  Shaofei Xie,et al.  DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles , 2010, The AAPS Journal.

[51]  V. C. Malshe,et al.  Polyethylene sebacate: genotoxicity, mutagenicity evaluation and application in periodontal drug delivery system. , 2009, Journal of pharmaceutical sciences.

[52]  Robert Langer,et al.  PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. , 2009, Biomaterials.

[53]  A. Fadda,et al.  Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: in vitro and in vivo evaluation , 2009, Journal of liposome research.

[54]  R. Curi,et al.  Soy lecithin supplementation alters macrophage phagocytosis and lymphocyte response to concanavalin A: a study in alloxan‐induced diabetic rats , 2008, Cell biochemistry and function.

[55]  S. Antimisiaris,et al.  Release of rifampicin from chitosan, PLGA and chitosan-coated PLGA microparticles. , 2008, Colloids and surfaces. B, Biointerfaces.

[56]  Robert Langer,et al.  Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. , 2008, ACS nano.

[57]  R. Dhand.  New frontiers in aerosol delivery during mechanical ventilation. , 2004, Respiratory care.

[58]  P. Coutinho,et al.  Effect of pH on the Control Release of Microencapsulated Dye in Lecithin Liposomes. II , 2003, Journal of liposome research.

[59]  M. Khan,et al.  Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[60]  L. Heifets,et al.  Nanoparticles as Antituberculosis Drugs Carriers: Effect on Activity Against Mycobacterium tuberculosis in Human Monocyte-Derived Macrophages , 2000 .

[61]  F. Ahsan,et al.  Particle engineering to enhance or lessen particle uptake by alveolar macrophages and to influence the therapeutic outcome. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[62]  S. Moein Moghimi,et al.  Recognition by Macrophages and Liver Cells of Opsonized Phospholipid Vesicles and Phospholipid Headgroups , 2004, Pharmaceutical Research.